Similar drugsTo uncover
Dosage form: & nbsppills
Composition:

For one tablet:

Active substance:

Ecdisten in terms of 100% substance

0.005 g

Auxiliary substances:

Sugar (sucrose)

- 0.089 g

Potato starch

0.005 g

Calcium stearate

-0,001 g

Weight of a tablet

- 0.1 g

Description:

Tablets are round, flat-cylindrical, with a facet, from white to white with a yellowish tint of color.

Pharmacotherapeutic group:metabolic
ATX: & nbsp
  • Other anabolic steroid drugs
  • Pharmacodynamics:

    Natural connection of the steroid structure from the roots and rhizomes of levzeya safflower; has a tonic effect, promotes the enhancement of protein synthesis in the body. Increases mental and physical performance.

    Indications:

    Asthenic syndrome associated with the weakening of protein-synthesizing processes; with long intoxications, infections; mental and physical overwork; among athletes, as a medicine, which increases the speed and strength in the period of preparation for the competition.

    Contraindications:

    Increased individual sensitivity to the drug components, nervous excitement, insomnia, arterial hypertension, epilepsy, hyperkinesis, stomach and duodenal ulcer (at the stage of exacerbation), congenital intolerance to fructose,glucose-galactose malabsorption, sugar / isomaltase deficiency, pregnancy and the period of breastfeeding, age to 18 years.

    If you have any of the listed diseases, before taking the drug, be sure to consult a doctor.

    Carefully:

    Patients with diabetes mellitus and people on a diet with a reduced carbohydrate content.

    Dosing and Administration:

    Inside, to 0,005-0,01 g (1-2 tablets) 3 times a day after meals; course of treatment - 15-20 days; on the recommendation of a doctor, a repeat course of treatment can be performed in 1-2 weeks; in sports medicine apply to 0.01 g (2 tablets) 3 times a day for 2-3 weeks; the maximum single dose is 0.01 g (2 tablets), the highest daily dose is 0.03 g (6 tablets).

    Side effects:

    Possible insomnia, increased blood pressure, pain in the epigastric region.

    If any of the side effects listed in the instruction are aggravated, or you notice any other side effects not listed in the instructions, tell your doctor.

    Overdose:

    Overdose may increase the dose-dependent adverse reactions.

    Treatment: symptomatic.

    Interaction:

    With simultaneous use, it is possible to increase the effect of stimulants and analeptics (caffeine, camphor, phenamine); the drug is an antagonist of drugs that depress the central nervous system (including neuroleptics, barbiturates, tranquilizers, anticonvulsant drugs).

    Special instructions:

    To achieve the effect simultaneously with the use of the drug, it is necessary to obtain adequate amounts of proteins, fats, carbohydrates, vitamins and minerals with food.

    In case of side effects, including to avoid sleep disturbances, it is advisable to reduce the dose or stop the evening intake of the drug.

    Patients with diabetes should take into account that one tablet of the drug contains about 0.099 g of carbohydrates (0.008 XE).

    Effect on the ability to drive transp. cf. and fur:

    The use of the drug does not affect the ability to drive vehicles and engage in other potentially hazardous activities that require increased concentration and speed of psychomotor reactions.

    Form release / dosage:Tablets, 5 mg.
    Packaging:

    For 10 tablets in a planar cell package.

    3 or 5 contour mesh packages together with instructions for use in a pack of cardboard.

    Storage conditions:

    In a dry, the dark place at a temperature of no higher than 25 ° C.

    Keep out of the reach of children.

    Shelf life:

    2 years.

    Do not use after the expiration date.

    Terms of leave from pharmacies:On prescription
    Registration number:LP-001600
    Date of registration:22.03.2012
    Date of cancellation:2017-03-22
    The owner of the registration certificate:VIFITEH, CJSC VIFITEH, CJSC Russia
    Manufacturer: & nbsp
    Representation: & nbspVIFITEH, CJSCVIFITEH, CJSC
    Information update date: & nbsp22.03.2016
    Illustrated instructions
      Instructions
      Up